(2R,3R,4R,5R,6S)-2-[(2R,3R,4R,5R,6S)-2-[(3S,4R,5S,6R)-6-[(2S,3R,4S,5R)-4,5-dihydroxy-2-[[(1S,2S,4S,6S,7S,8R,9S,12S,13R,16R)-6-hydroxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-16-yl]oxy]oxan-3-yl]oxy-4-hydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-methyloxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Details

Top
Internal ID f0c90d67-886b-489f-9263-3e3c178fb252
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins
IUPAC Name (2R,3R,4R,5R,6S)-2-[(2R,3R,4R,5R,6S)-2-[(3S,4R,5S,6R)-6-[(2S,3R,4S,5R)-4,5-dihydroxy-2-[[(1S,2S,4S,6S,7S,8R,9S,12S,13R,16R)-6-hydroxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-16-yl]oxy]oxan-3-yl]oxy-4-hydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-methyloxan-3-yl]oxy-6-methyloxane-3,4,5-triol
SMILES (Canonical) CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(CO6)O)O)OC7C(C(C(CO7)OC8C(C(C(C(O8)C)O)O)OC9C(C(C(C(O9)C)O)O)O)O)OC2C(C(C(CO2)O)O)O)C)C)OC1(CCC(C)COC1C(C(C(C(O1)CO)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@H](C5)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O[C@@H]7[C@H]([C@@H]([C@H](CO7)O[C@@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O[C@@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)O)O[C@H]2[C@@H]([C@H]([C@@H](CO2)O)O)O)C)C)O[C@]1(CC[C@@H](C)CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O
InChI InChI=1S/C60H98O29/c1-22(18-77-52-47(74)44(71)41(68)34(17-61)84-52)9-14-60(76)23(2)36-33(89-60)16-30-28-8-7-26-15-27(10-12-58(26,5)29(28)11-13-59(30,36)6)83-55-49(40(67)32(63)20-79-55)88-56-50(86-53-46(73)39(66)31(62)19-78-53)42(69)35(21-80-56)85-57-51(45(72)38(65)25(4)82-57)87-54-48(75)43(70)37(64)24(3)81-54/h7,22-25,27-57,61-76H,8-21H2,1-6H3/t22-,23+,24+,25+,27-,28-,29+,30+,31-,32-,33+,34-,35+,36+,37+,38+,39+,40+,41-,42-,43-,44+,45-,46-,47-,48-,49-,50+,51-,52-,53+,54-,55+,56-,57-,58+,59+,60+/m1/s1
InChI Key HPAZMTUJBDFPDN-WVKUCCCPSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C60H98O29
Molecular Weight 1283.40 g/mol
Exact Mass 1282.61937708 g/mol
Topological Polar Surface Area (TPSA) 444.00 Ų
XlogP -3.70
Atomic LogP (AlogP) -4.41
H-Bond Acceptor 29
H-Bond Donor 16
Rotatable Bonds 17

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R,3R,4R,5R,6S)-2-[(2R,3R,4R,5R,6S)-2-[(3S,4R,5S,6R)-6-[(2S,3R,4S,5R)-4,5-dihydroxy-2-[[(1S,2S,4S,6S,7S,8R,9S,12S,13R,16R)-6-hydroxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-16-yl]oxy]oxan-3-yl]oxy-4-hydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-methyloxan-3-yl]oxy-6-methyloxane-3,4,5-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7571 75.71%
Caco-2 - 0.8784 87.84%
Blood Brain Barrier - 0.6750 67.50%
Human oral bioavailability - 0.8286 82.86%
Subcellular localzation Mitochondria 0.7376 73.76%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8590 85.90%
OATP1B3 inhibitior + 0.8994 89.94%
MATE1 inhibitior - 0.9612 96.12%
OCT2 inhibitior - 0.5500 55.00%
BSEP inhibitior + 0.8590 85.90%
P-glycoprotein inhibitior + 0.7435 74.35%
P-glycoprotein substrate + 0.7360 73.60%
CYP3A4 substrate + 0.7591 75.91%
CYP2C9 substrate - 0.8020 80.20%
CYP2D6 substrate - 0.8336 83.36%
CYP3A4 inhibition - 0.9268 92.68%
CYP2C9 inhibition - 0.9182 91.82%
CYP2C19 inhibition - 0.9234 92.34%
CYP2D6 inhibition - 0.9343 93.43%
CYP1A2 inhibition - 0.9102 91.02%
CYP2C8 inhibition + 0.7750 77.50%
CYP inhibitory promiscuity - 0.9302 93.02%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5116 51.16%
Eye corrosion - 0.9898 98.98%
Eye irritation - 0.9007 90.07%
Skin irritation + 0.4929 49.29%
Skin corrosion - 0.9426 94.26%
Ames mutagenesis - 0.7600 76.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7972 79.72%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 0.8875 88.75%
skin sensitisation - 0.9214 92.14%
Respiratory toxicity + 0.7111 71.11%
Reproductive toxicity + 0.9222 92.22%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity - 0.9471 94.71%
Acute Oral Toxicity (c) I 0.5904 59.04%
Estrogen receptor binding + 0.8413 84.13%
Androgen receptor binding + 0.7124 71.24%
Thyroid receptor binding + 0.6105 61.05%
Glucocorticoid receptor binding + 0.7385 73.85%
Aromatase binding + 0.6535 65.35%
PPAR gamma + 0.8285 82.85%
Honey bee toxicity - 0.5875 58.75%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity - 0.5700 57.00%
Fish aquatic toxicity + 0.9176 91.76%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.94% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 98.60% 95.93%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.94% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 93.32% 97.09%
CHEMBL2581 P07339 Cathepsin D 93.01% 98.95%
CHEMBL1994 P08235 Mineralocorticoid receptor 92.91% 100.00%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 91.61% 95.89%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 91.26% 94.45%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.41% 89.00%
CHEMBL1937 Q92769 Histone deacetylase 2 90.37% 94.75%
CHEMBL221 P23219 Cyclooxygenase-1 90.17% 90.17%
CHEMBL242 Q92731 Estrogen receptor beta 90.11% 98.35%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 89.95% 92.86%
CHEMBL5608 Q16288 NT-3 growth factor receptor 88.43% 95.89%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 87.75% 97.33%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 87.72% 89.05%
CHEMBL3359 P21462 Formyl peptide receptor 1 87.35% 93.56%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 86.93% 92.88%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 86.16% 94.08%
CHEMBL2996 Q05655 Protein kinase C delta 86.06% 97.79%
CHEMBL2360 P00492 Hypoxanthine-guanine phosphoribosyltransferase 84.79% 87.38%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 84.43% 94.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 83.97% 86.33%
CHEMBL2140 P48775 Tryptophan 2,3-dioxygenase 82.97% 98.46%
CHEMBL2842 P42345 Serine/threonine-protein kinase mTOR 82.65% 92.78%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 82.38% 91.24%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 82.12% 100.00%
CHEMBL4581 P52732 Kinesin-like protein 1 81.42% 93.18%
CHEMBL5163 Q9NY46 Sodium channel protein type III alpha subunit 81.31% 96.90%
CHEMBL2335 P42785 Lysosomal Pro-X carboxypeptidase 80.76% 100.00%
CHEMBL1871 P10275 Androgen Receptor 80.59% 96.43%
CHEMBL218 P21554 Cannabinoid CB1 receptor 80.46% 96.61%
CHEMBL5028 O14672 ADAM10 80.45% 97.50%
CHEMBL4208 P20618 Proteasome component C5 80.40% 90.00%
CHEMBL253 P34972 Cannabinoid CB2 receptor 80.37% 97.25%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Balanites aegyptiaca

Cross-Links

Top
PubChem 163025193
LOTUS LTS0020727
wikiData Q105031625